Literature DB >> 29472686

A review of the longevity of effect of botulinum toxin in wrinkle treatments.

G Wright, A Lax, S B Mehta1.   

Abstract

Botulinum toxin is widely used in facial rhytide treatments. The duration of its effects influences treatment intervals, cost and convenience to the patient. These are key factors in successful aesthetic procedures. A review of the literature found that duration of effect was between two and six months, with most experiencing loss of maximal contraction for three to four months. Treatments may last between three to four months, and occasionally up to six months. No specific definition of effectiveness/efficacy has been described and used to measure comparable end points. Additional research should help clarify the impact of brand, age, gender, ethnicity, repetition of treatment and zinc-phytase supplementation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29472686     DOI: 10.1038/sj.bdj.2018.126

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  29 in total

Review 1.  The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status.

Authors:  Sarah Connor Gorber; Sean Schofield-Hurwitz; Jill Hardt; Geneviève Levasseur; Mark Tremblay
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

2.  A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines.

Authors:  Matthias Imhof; Ulrich Kühne
Journal:  J Clin Aesthet Dermatol       Date:  2011-10

3.  Developing clinical guidelines.

Authors:  P G Shekelle; S H Woolf; M Eccles; J Grimshaw
Journal:  West J Med       Date:  1999-06

Review 4.  Dilution and storage of botulinum toxin.

Authors:  A W Klein
Journal:  Dermatol Surg       Date:  1998-11       Impact factor: 3.398

5.  Effect of dietary zinc and phytase supplementation on botulinum toxin treatments.

Authors:  John C Koshy; Safa E Sharabi; Evan M Feldman; Larry H Hollier; James R Patrinely; Charles N S Soparkar
Journal:  J Drugs Dermatol       Date:  2012-04       Impact factor: 2.114

6.  Botulinum toxin for the treatment of hyperfunctional lines of the face.

Authors:  A Blitzer; M F Brin; M S Keen; J E Aviv
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1993-09

7.  A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI.

Authors:  Pearl E Grimes; Dwana Shabazz
Journal:  Dermatol Surg       Date:  2009-02-22       Impact factor: 3.398

8.  Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study.

Authors:  Welf Prager; Eva K Bee; Isabel Havermann; Ina Zschocke
Journal:  Clin Interv Aging       Date:  2013-04-24       Impact factor: 4.458

9.  Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.

Authors:  Ramtin Kassir; Aparanjita Kolluru; Martin Kassir
Journal:  Dermatol Ther (Heidelb)       Date:  2013-08-16

10.  A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects.

Authors:  Kiyonori Harii; Makoto Kawashima
Journal:  Aesthetic Plast Surg       Date:  2008-07-29       Impact factor: 2.326

View more
  3 in total

Review 1.  [New botulinum toxins for aesthetic dermatology : A comprehensive review].

Authors:  A Patil; M Kassir; U Wollina; M Goldust
Journal:  Hautarzt       Date:  2021-04-06       Impact factor: 0.751

Review 2.  The use of botulinum toxin in keloid scar management: a literature review.

Authors:  Catrin Sohrabi; Ioannis Goutos
Journal:  Scars Burn Heal       Date:  2020-06-26

Review 3.  Botulinum toxin A for the treatment of first bite syndrome-a systematic review.

Authors:  Noah E Shaikh; Haseeb A Jafary; John W Behnke; Meghan T Turner
Journal:  Gland Surg       Date:  2022-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.